West Pharmaceutical Services | WST - Assets


West Pharmaceutical Services reported $4.27B in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Align Technology USD 6.23B 141K Dec/2025
Avanos Medical USD 1.07B 6M Dec/2025
Baxter International USD 20.06B 1.01B Dec/2025
Becton, Dickinson and Co. USD 54.84B 484M Dec/2025
Cerus USD 215.18M 2.11M Sep/2025
Charles River Laboratories USD 7.14B 378.39M Dec/2025
Cooper Companies USD 12.39B 18.1M Sep/2025
Dentsply International USD 5.65B 416M Sep/2025
Haemonetics USD 2.49B 48.73M Dec/2025
ICU Medical USD 4.05B 52.39M Dec/2025
Insulet USD 3.19B 161.1M Dec/2025
Integra LifeSciences USD 3.65B 21.45M Sep/2025
IQVIA Holdings USD 29.94B 1.22B Dec/2025
J&J USD 199.21B 6.39B Dec/2025
Medtronic USD 91.35B 374M Sep/2025
Merit Medical Systems USD 2.63B 44.95M Sep/2025
Neogen USD 3.36B 18.21M Sep/2025
OraSure Technologies USD 423.1M 21.94M Sep/2025
Quidel USD 5.77B 94.2M Dec/2025
Repligen USD 2.92B 22.08M Sep/2025
Rockwell Medical USD 52.62M 1.34M Jun/2025
Solventum Corp USD 13.97B 1.1B Sep/2025
STAAR Surgical USD 456.36M 18.58M Sep/2025
Terumo JPY 2.26T 362.12B Dec/2025
Utah Medical Products USD 121.98M 1.17M Sep/2025
West Pharmaceutical Services USD 4.27B 164.2M Dec/2025